Study: Non-diabetes Status After IGT Diagnosis and Long-Term Risks
Background
The study aimed to clarify the association between years of non-diabetes status after diagnosis of impaired glucose tolerance (IGT) and the risk of long-term death and cardiovascular outcomes.
Methods and Findings
540 individuals with IGT from the Da Qing Diabetes Prevention Study were included in a post hoc analysis. Participants were monitored for 30 years after a 6-year lifestyle intervention trial. The analysis showed that maintaining non-diabetes status for at least 4 years was associated with a significant reduction in the risk of death and vascular complications.
Conclusions
The study observed that maintaining several years of non-diabetes status after IGT diagnosis was linked to a significant reduction in long-term risk of death and vascular complications. Maintaining at least 4 years of non-diabetes status may be necessary to achieve a significant risk reduction for most outcomes.
Value of Clinical Trials and Practical Solutions
Clinical trials are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research into an easily accessible knowledge base for clinicians, extending the benefits of clinical trials into everyday medical practice.
Streamlining Healthcare Operations
In today’s healthcare environment, streamlining operations is crucial. Our mobile apps support scheduling, monitoring treatments, and telemedicine, making it easier to manage patient care and expand services digitally.
Enhancing Workflows with AI
By using AI, clinics can enhance their workflows and improve patient outcomes, reducing paper routines. Learn more about how we can help at aidevmd.com.
